Meta-GWAS and Meta-Analysis of Exome Array Studies Do Not Reveal Genetic Determinants of Serum Hepcidin
Serum hepcidin concentration is regulated by iron status, inflammation, erythropoiesis and numerous other factors, but underlying processes are incompletely understood. We studied the association of common and rare single nucleotide variants (SNVs) with serum hepcidin in one Italian study and two la...
Saved in:
Published in | PloS one Vol. 11; no. 11; p. e0166628 |
---|---|
Main Authors | , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Public Library of Science
15.11.2016
Public Library of Science (PLoS) |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Serum hepcidin concentration is regulated by iron status, inflammation, erythropoiesis and numerous other factors, but underlying processes are incompletely understood. We studied the association of common and rare single nucleotide variants (SNVs) with serum hepcidin in one Italian study and two large Dutch population-based studies. We genotyped common SNVs with genome-wide association study (GWAS) arrays and subsequently performed imputation using the 1000 Genomes reference panel. Cohort-specific GWAS were performed for log-transformed serum hepcidin, adjusted for age and gender, and results were combined in a fixed-effects meta-analysis (total N 6,096). Six top SNVs (p<5x10-6) were genotyped in 3,821 additional samples, but associations were not replicated. Furthermore, we meta-analyzed cohort-specific exome array association results of rare SNVs with serum hepcidin that were available for two of the three cohorts (total N 3,226), but no exome-wide significant signal (p<1.4x10-6) was identified. Gene-based meta-analyses revealed 19 genes that showed significant association with hepcidin. Our results suggest the absence of common SNVs and rare exonic SNVs explaining a large proportion of phenotypic variation in serum hepcidin. We recommend extension of our study once additional substantial cohorts with hepcidin measurements, GWAS and/or exome array data become available in order to increase power to identify variants that explain a smaller proportion of hepcidin variation. In addition, we encourage follow-up of the potentially interesting genes that resulted from the gene-based analysis of low-frequency and rare variants. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 Conceptualization: TEG NV MT CB PM CC DT SHV PH DWS. Formal analysis: TEG NV MT CB. Funding acquisition: PM CC DT SHV PH DWS. Investigation: TEG NV MT CB PM CC DT SHV PH DWS. Methodology: TEG NV MT CB PM CC DT SHV PH DWS. Project administration: TEG SHV DWS. Resources: FD AJG DG LALMK FCGJS MAS PM CC DT PH DWS. Software: MAS FD. Supervision: PM CC DT SHV PH DWS. Validation: TEG NV MT AJG. Visualization: TEG NV. Writing – original draft: TEG. Writing – review & editing: NV MT CB FD AJG DG LALMK FCGJS MAS PM CC DT SHV PH DWS. Competing Interests: DWS is an employee of Radboudumc, that offers hepcidin measurements to the scientific, medical and pharmaceutical communities at a fee-for-service bases via the www.hepcidinanalysis.com initiative. The remaining authors declare that they have no competing interests. The competing interests do not alter our adherence to PLOS ONE policies on sharing data and materials. PM and CC also contributed equally to this work. DT, SHV, PH, and DWS also contributed equally to this work. |
ISSN: | 1932-6203 1932-6203 |
DOI: | 10.1371/journal.pone.0166628 |